Oligodendrocyte Inclusion Pathology in Fragile X‐Associated Tremor/Ataxia Syndrome
Movement Disorders · 2026
DOI: 10.1002/mds.70145 ↗Kurz gefasst
Fachartikel in der Zeitschrift Movement Disorders, 2026. Verfasst von Yingratana McLennan und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, School of Medicine, University of California Davis Health, Sacramento, California, USA. Hauptthemen laut MEDLINE: Fragile X Syndrome, Tremor, Ataxia, Oligodendroglia. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 17 Literaturangaben. Gefördert von: NINDS NIH HHS, Shriners Hospitals for Children, National Institute of Neurological Disorders and Stroke.
Abstract (Originalsprache)
Background
Fragile X‐associated tremor/ataxia syndrome (FXTAS) is a neurodegenerative disorder marked by white matter degeneration and intranuclear inclusions. While astrocytic and neuronal inclusions are well‐documented, oligodendrocytes were previously thought to lack such pathology.
Objective
To demonstrate that oligodendrocytes in the prefrontal cortex of FXTAS patients do harbor intranuclear inclusions, with significantly higher burden in white matter than gray matter.
Methods
Ubiquitin and p62 immunofluorescence and enzymatic staining were employed to confirm the presence of intranuclear inclusions in oligodendrocytes across multiple brain regions.
Results
Oligodendrocytes contain inclusions and inclusion burden is correlated with FMR1 CGG repeat length ( ρ = 0.97, P < 0.001) in white matter.
Conclusions
These findings implicate oligodendrocyte dysfunction in FXTAS pathogenesis which may contribute to demyelination and white matter degeneration. Our data emphasize the need to consider cell type‐specific mechanisms in FXTAS and support future therapeutic efforts aimed at restoring glial proteostasis. © 2025 International Parkinson and Movement Disorder Society.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pathology and Laboratory Medicine, School of Medicine, University of California Davis Health, Sacramento, California, USA.
- Institute for Pediatric Regenerative Medicine and Shriners Hospital for Children, Sacramento, California, USA.
- Centro de Estudios Cerebrales, Facultad de Salud, Universidad del Valle, Cali, Colombia.
- Departamento de Ciencias Básicas de la Salud, Pontificia Universidad Javeriana, Cali, Colombia.
- Clínica Imbanaco, Grupo Quirónsalud, Cali, Colombia.
- Department of Biochemistry and Molecular Medicine, School of Medicine, University of California, Davis, Davis, California, USA.
ORCID-Profile: Yingratana McLennan, Veronica Martínez-Cerdeño
Förderung
- NINDS NIH HHS
- Shriners Hospitals for Children
- National Institute of Neurological Disorders and Stroke
Zitieren
APA
McLennan, Y., Aliashrafzadeh, H., Zirkelbach-Ngai, F., McKenzie, F., Dufour, B. D., Becerra-Hernández, L. V., Escobar, A. S., Tassone, F., Hagerman, P., Hagerman, R., & Martínez-Cerdeño, V. (2026). Oligodendrocyte Inclusion Pathology in Fragile X‐Associated Tremor/Ataxia Syndrome. Movement Disorders. https://doi.org/10.1002/mds.70145
Vancouver
McLennan Y, Aliashrafzadeh H, Zirkelbach-Ngai F, McKenzie F, Dufour BD, Becerra-Hernández LV, et al. Oligodendrocyte Inclusion Pathology in Fragile X‐Associated Tremor/Ataxia Syndrome. Movement Disorders. 2026. doi:10.1002/mds.70145
BibTeX
@article{McLennan2026,
author = {McLennan, Yingratana and Aliashrafzadeh, Hassan and Zirkelbach-Ngai, Faith and McKenzie, Forrest and Dufour, Brett D and Becerra-Hernández, Lina V and Escobar, Adolfo Sanchez and Tassone, Flora and Hagerman, Paul and Hagerman, Randi and Martínez-Cerdeño, Veronica},
title = {Oligodendrocyte Inclusion Pathology in Fragile X‐Associated Tremor/Ataxia Syndrome},
journal = {Movement Disorders},
year = {2026},
doi = {10.1002/mds.70145}
}
EUVIMED